Search result for 'dme'

Godavari Biorefineries and ICT Mumbai launch project transforming greenhouse gases into clean fuel (DME). Indusind appoints CHRO. NSDL revamps FPI portal.

Lupin collaborates with Sandoz to commercialize biosimilar ranibizumab in multiple regions. Sandoz to handle commercialization, Lupin to manufacture.

Biocon Biologics receives Health Canada approval for its biosimilar Yesafili injection, used to treat various eye ailments. Launch is scheduled for July 4, 2025.

Lupin has entered into a licence agreement with SteinCares for commercialisation of biosimilar ranibizumab across Latin America, excluding Mexico and Argentina.

Biocon Biologics has secured market entry for its biosimilar product Yesafili in the US after reaching a settlement agreement with Regeneron. Yesafili, a biosimilar of Eylea (aflibercept), will be...

DMEDL, an NHAI subsidiary, has raised Rs 775 crore through green bonds for sustainable infrastructure projects in the roads and highways sector, setting a benchmark for green financing in the...

NHAI's DME Development Ltd will raise Rs 1,000 crore through green bonds to implement climate-friendly measures on the Delhi-Mumbai Expressway project. The funds will be used for avenue plantation,...

Noida International Airport starts test flights to calibrate ground-based radio navigation systems, ensuring safe and efficient operations before its commercial launch.

Roche Pharma India launches Vabysmo (faricimab) for age-related macular degeneration and diabetic macular edema, the two leading causes of vision loss.